{"id":195,"date":"2026-03-24T08:52:36","date_gmt":"2026-03-24T08:52:36","guid":{"rendered":"https:\/\/air-compressor-for-laser-cutter.com\/?p=195"},"modified":"2026-03-24T09:22:38","modified_gmt":"2026-03-24T09:22:38","slug":"oil-free-air-compressors-for-pharmaceutical-manufacturing","status":"publish","type":"post","link":"https:\/\/air-compressor-for-laser-cutter.com\/sv\/ansokan\/oil-free-air-compressors-for-pharmaceutical-manufacturing\/","title":{"rendered":"Oil-Free Air Compressors for Pharmaceutical Manufacturing"},"content":{"rendered":"
\n

<\/p>\n

\n
\n

GMP-Compliant \u00a0\u00b7\u00a0 ISO 8573-1 Class 0 \u00a0\u00b7\u00a0 MHRA & UKCA Certified<\/p>\n

Oil-Free Air Compressors for Pharmaceutical Manufacturing<\/h2>\n

The precision-engineered compressed air solution powering drug production lines, aseptic filling, sterile packaging, and fermentation processes across UK pharmaceutical facilities \u2014 meeting the most stringent GMP and MHRA standards without compromise.<\/p>\n

\ud83d\ude80 Request a Free Custom Quote \u2192<\/a><\/p>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Why Pharmaceutical Plants Cannot Compromise on Compressed Air Purity<\/h2>\n

\"luftkompressor\" In pharmaceutical manufacturing, compressed air is far more than a background utility \u2014 it is a direct-contact process medium that participates in every critical stage of drug production. From the pneumatic actuation of sterile filling valves and the blow moulding of PET bottles for oral liquids, to the sparging of bioreactors during large-scale API fermentation and the conveying of powders in solid-dosage manufacturing, the purity and reliability of the compressed air supply is inseparable from product quality and patient safety. Even microscopic traces of lubricating oil in the compressed air stream \u2014 invisible to the naked eye yet detectable at concentrations below 0.01 mg\/m\u00b3 \u2014 are sufficient to adulterate a batch, invalidate a cleanroom qualification, or trigger a costly regulatory investigation by the Medicines and Healthcare products Regulatory Agency (MHRA). The consequences of using inadequate compressed air in a licensed UK pharmaceutical facility range from product recalls and batch rejections to suspension of manufacturing authorisations and, in the most serious cases, direct harm to patients who depend on the integrity of the medicines they receive.<\/p>\n

The regulatory landscape governing compressed air quality in UK pharmaceutical manufacturing is both comprehensive and non-negotiable. The MHRA’s Rules and Guidance for Pharmaceutical Manufacturers and Distributors \u2014 commonly known as the “Orange Guide” \u2014 incorporates EU GMP Annex 1 requirements for sterile medicinal products, which explicitly address the quality of compressed gases used in manufacturing. Compressed air intended for direct product contact, pneumatic transport of APIs, or use within cleanroom environments must meet ISO 8573-1:2010 Class 0 oil content (meaning no detectable oil aerosol, vapour, or liquid), Class 1 particle cleanliness (maximum 0.1 \u00b5m particle size), and Class 1 moisture content (pressure dew point of \u2264 \u221270\u00b0C). These are not aspirational targets; they are legal prerequisites for holding a Manufacturing Authorisation (MA) for sterile or parenteral products at any site operating under MHRA oversight, whether in London, Manchester, Edinburgh, or any other UK location.<\/p>\n

An oil-free air compressor \u2014 specifically designed to deliver completely hydrocarbon-free compressed air without reliance on any lubricating oil in the compression chamber \u2014 is the only machine category capable of meeting these requirements at source. When correctly paired with a pharmaceutical-specification drying and filtration train, an oil-free screw or centrifugal compressor provides the confirmed Class 0 purity that GMP validation demands. Ever Power supplies a comprehensive range of oil-free air compressors specifically configured for pharmaceutical applications across the United Kingdom, with full documentation support for GMP qualification activities including IQ, OQ, and PQ protocols.\"luftkompressor\"<\/p>\n<\/div>\n

\ud83d\udce9 Enquire About This Product \u2014 Get a Price Today<\/a><\/div>\n

<\/p>\n

\n

The Hidden Risk: Why Oil-Lubricated Compressors Fail Pharmaceutical GMP Requirements<\/h2>\n

\"luftkompressor\"Conventional oil-lubricated screw compressors inject lubricating oil directly into the compression stage to reduce heat, seal internal clearances, and protect rotor surfaces. While this design is entirely appropriate for general industrial use, it creates an inherent contamination pathway that cannot be fully resolved by downstream filtration alone. Even the most advanced coalescing filters and activated-carbon adsorbers \u2014 installed and maintained in perfect condition \u2014 carry a residual risk of oil carry-over, particularly at elevated temperatures or when filter elements approach the end of their service life. In a pharmaceutical manufacturing environment where a single contaminated batch may represent hundreds of thousands of pounds in drug product value, plus the incalculable cost of patient harm and regulatory action, this residual risk is simply unacceptable.<\/p>\n

Beyond the contamination risk, oil-lubricated compressors introduce a documentation burden that is difficult to manage under GMP. Every filter change, oil sample, and oil analysis result must be recorded, reviewed, and linked to product batch records. If an oil carry-over event is suspected \u2014 even without confirmed contamination \u2014 a full investigation is required, potentially leading to batch holds across multiple product lines. Regulatory inspectors from the MHRA, and inspectors conducting joint audits with European partners under the Mutual Recognition Agreement, routinely scrutinise compressed air systems and will question any facility that relies on oil-lubricated compressors with downstream filtration as the primary means of meeting Class 0 oil content. By contrast, an oil-free air compressor simply eliminates this risk vector entirely, greatly simplifying GMP compliance and inspection readiness.<\/p>\n<\/div>\n

<\/p>\n

\n

Technical Parameters: Ever Power Pharmaceutical-Grade Oil-Free Air Compressors<\/h2>\n

All models are available with custom specifications for UK pharmaceutical sites. Contact us for bespoke sizing and GMP validation documentation packages.<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Parameter<\/th>\nSpecification \/ Range<\/th>\nReference Standard<\/th>\n<\/tr>\n<\/thead>\n
Compressor Technology<\/td>\nDry-Running Oil-Free Twin-Screw \/ Water-Injected Oil-Free Screw<\/td>\nISO 8573-1:2010<\/td>\n<\/tr>\n
Oil Content in Delivered Air<\/td>\n< 0.001 mg\/m\u00b3 (Class 0 \u2014 Zero Detectable Oil)<\/td>\nISO 8573-1 Klass 0<\/td>\n<\/tr>\n
Working Pressure Range<\/td>\n5 \u2013 13 bar (0.5 \u2013 1.3 MPa) \u2014 adjustable per process requirement<\/td>\nProcess-dependent<\/td>\n<\/tr>\n
Free Air Delivery (FAD)<\/td>\n1.0 \u2013 100 m\u00b3\/min (scalable multi-unit solutions available)<\/td>\nISO 1217 Annex C<\/td>\n<\/tr>\n
Motor Drive Power<\/td>\n7.5 kW \u2013 750 kW (IE3 \/ IE4 Premium Efficiency)<\/td>\nIEC 60034-30-1<\/td>\n<\/tr>\n
Pressure Dew Point (with integrated dryer)<\/td>\n\u221240\u00b0C to \u221270\u00b0C PDP (Class 1 moisture)<\/td>\nISO 8573-1 Class 1<\/td>\n<\/tr>\n
Particulate Filtration (final stage)<\/td>\n\u2264 0.1 \u00b5m particle size @ 99.9999% efficiency<\/td>\nISO 8573-1 Class 1<\/td>\n<\/tr>\n
Sound Pressure Level<\/td>\n62 \u2013 72 dB(A) measured at 1 m distance<\/td>\nISO 2151<\/td>\n<\/tr>\n
Cooling Configuration<\/td>\nAir-Cooled or Water-Cooled (site-specific selection)<\/td>\nEngineered to site conditions<\/td>\n<\/tr>\n
Control System<\/td>\nIntelligent PLC with remote SCADA \/ BMS integration<\/td>\n21 CFR Part 11 compatible<\/td>\n<\/tr>\n
Certifications & Compliance<\/td>\nISO 8573-1 Class 0, CE, UKCA, T\u00dcV S\u00dcD, GMP Documentation<\/td>\nUK & EU Market Approved<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Six Reasons UK Pharmaceutical Manufacturers Choose Ever Power Oil-Free Compressors<\/h2>\n

From compliance assurance to total lifecycle cost, our pharmaceutical air compressors are engineered to deliver on every dimension that matters to a GMP facility.<\/p>\n

\n
\n
\ud83d\udee1\ufe0f<\/div>\n

Guaranteed Class 0 Oil-Free Air at Source<\/h3>\n

The compression chamber contains zero lubricating oil. There is no downstream filtration dependency for oil removal \u2014 the compressor itself produces certified oil-free air every operating cycle. This absolute guarantee is essential for aseptic and parenteral manufacturing environments where any contamination pathway must be eliminated by design, not just controlled by a downstream barrier. Ever Power’s Class 0 certification is independently verified by T\u00dcV S\u00dcD and documented for inclusion in your compressed air system qualification package.<\/p>\n<\/div>\n

\n
\ud83d\udccb<\/div>\n

Comprehensive GMP Validation Documentation<\/h3>\n

Every Ever Power pharmaceutical oil-free compressor is supplied with a full validation documentation pack covering Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) protocols. Factory Acceptance Test (FAT) and Site Acceptance Test (SAT) procedures are included as standard, reducing your site qualification workload and compressing the timeline to GMP approval. All documentation is structured to satisfy MHRA inspection requirements and aligns with the ISPE Good Practice Guide for Compressed Air.<\/p>\n<\/div>\n

\n
\u26a1<\/div>\n

Variable-Speed Drive (VSD) for Maximum Energy Efficiency<\/h3>\n

Pharmaceutical manufacturing often involves highly variable air demand across different production shifts and process stages. Our VSD-equipped oil-free compressors automatically modulate motor speed to precisely match actual demand, reducing energy consumption by up to 35% compared to fixed-speed alternatives. With UK industrial electricity costs remaining elevated, the energy savings delivered by VSD technology typically achieve a return on investment within 18 to 24 months. All VSD models carry IE4 motor efficiency classification and meet the UK’s Enhanced Capital Allowance criteria for energy-saving plant.<\/p>\n<\/div>\n

\n
\ud83d\udd27<\/div>\n

Reduced Maintenance Burden, Lower Total Cost of Ownership<\/h3>\n

Without lubricating oil to manage, our pharmaceutical oil-free compressors eliminate a significant portion of the maintenance tasks that burden conventional lubricated machines \u2014 no oil changes, no oil analysis sampling, no oil separator element replacements, and no oil filter servicing. Service intervals are extended and maintenance procedures are simpler, reducing both planned downtime and the risk of unplanned maintenance-related production stoppages. Our UK service network provides rapid-response preventive maintenance contracts with guaranteed response times for pharmaceutical customers requiring continuous production support.<\/p>\n<\/div>\n

\n
\ud83c\udf21\ufe0f<\/div>\n

Heat Recovery for Pharmaceutical Process Integration<\/h3>\n

Up to 80% of the electrical energy input to an oil-free compressor can be recovered as usable heat. For pharmaceutical facilities with hot water requirements \u2014 process water heating, space heating, or Clean-In-Place (CIP) system pre-heating \u2014 Ever Power’s integrated heat recovery modules capture this energy and redirect it productively, further reducing the overall energy cost of the compressed air system. In a typical mid-size UK pharmaceutical plant running two oil-free compressors at 110 kW each, heat recovery can deliver annual energy savings equivalent to more than \u00a340,000 at current UK gas and electricity prices.<\/p>\n<\/div>\n

\n
\ud83d\udce1<\/div>\n

Smart Monitoring & 21 CFR Part 11 Compatible Controls<\/h3>\n

The intelligent PLC control system on every Ever Power pharmaceutical oil-free compressor provides real-time monitoring of all critical performance parameters \u2014 discharge pressure, temperature, oil content (via continuous dew point and total hydrocarbon monitoring), filter differential pressure, and running hours \u2014 with full data logging capability. Audit trail functionality meets 21 CFR Part 11 requirements for electronic records, facilitating integration with pharmaceutical batch records and site-wide quality management systems. Remote access via SCADA or BMS allows the engineering team to monitor the compressed air system from any authorised device.<\/p>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Key Application Scenarios: Where Oil-Free Compressed Air Is Essential in Pharmaceutical Production<\/h2>\n
\n
\n

\ud83d\udc8a Solid Dosage & Powder Handling<\/h3>\n

Tablet compression, capsule filling, and granulation processes require oil-free compressed air for pneumatic conveying of APIs and excipients, cleaning of tablet punches, and actuation of filling machinery. Any oil contamination at this stage directly affects the purity of the final drug product and could render an entire batch non-compliant with British Pharmacopoeia standards.<\/p>\n<\/div>\n

\n

\ud83d\udc89 Parenteral & Aseptic Filling Lines<\/h3>\n

Sterile filling of injectables, infusion bags, and prefilled syringes is the most demanding pharmaceutical application for compressed air. The oil-free compressor supplies the actuation air for filling heads, the overlay gas for oxygen-sensitive products, and the purging air for container-closure integrity testing \u2014 all in direct contact with sterile product. ISO 8573-1 Class 0 is non-negotiable here, and it must be demonstrated at every validation and routine monitoring interval.<\/p>\n<\/div>\n

\n

\ud83e\uddeb Bioreactor Sparging & Fermentation<\/h3>\n

Biopharmaceutical production processes \u2014 monoclonal antibody manufacturing, recombinant protein production, and vaccine antigen cultivation \u2014 rely on the sparging of oil-free compressed air or gas mixtures through bioreactor culture media to supply oxygen and control pH. Contamination of the sparge gas stream with lubricating oil residues would compromise cell culture viability and product quality, potentially destroying a batch worth millions of pounds.<\/p>\n<\/div>\n

\n

\ud83e\uded9 Blow Moulding & Container Forming<\/h3>\n

PET bottle blow moulding for oral liquid pharmaceuticals \u2014 syrups, solutions, and suspensions \u2014 requires high-pressure oil-free compressed air (typically 35\u201340 bar for stretch blow moulding) to form the primary container that will directly contact the drug product. The British Pharmacopoeia requirements for container purity, combined with GMP expectations for primary packaging, make oil-free air the only compliant choice for pharmaceutical blow moulding operations at UK sites.<\/p>\n<\/div>\n

\n

\ud83c\udfed Cleanroom Pressurisation & HVAC Support<\/h3>\n

Grade A, B, C, and D classified cleanrooms in pharmaceutical manufacturing facilities use compressed air in pressurisation systems and as an instrument gas for critical HVAC control valves. The continuous, reliable delivery of oil-free compressed air to these systems is essential for maintaining the differential pressure cascades that prevent cross-contamination between cleanroom grades \u2014 a fundamental principle of aseptic process design validated to EU GMP Annex 1 requirements.<\/p>\n<\/div>\n

\n

\ud83d\udd2c Laboratory & QC Testing Instruments<\/h3>\n

Pharmaceutical quality control and analytical laboratories depend on oil-free compressed air as a carrier and blanket gas for HPLC, gas chromatography, atomic absorption spectroscopy, and dissolution testing equipment. Laboratory instruments are particularly sensitive to hydrocarbon contamination in the gas supply, which can produce false analytical results, damage detector components, and invalidate test data \u2014 with potential consequences for product release decisions and batch disposition across the manufacturing site.<\/p>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Serving the UK Pharmaceutical Sector: From London Biotech Hubs to Scottish Manufacturing Sites<\/h2>\n

\"luftkompressor\"The United Kingdom pharmaceutical industry is one of the largest and most technically advanced in the world, employing more than 73,000 people directly and contributing approximately \u00a314.5 billion to UK exports annually. Major manufacturing clusters are established in the East of England \u2014 particularly Cambridge and Stevenage, home to significant biopharmaceutical production facilities \u2014 as well as in the North West of England, the West Midlands, and Scotland, where sites in Edinburgh, Livingston, and Stirling support a substantial proportion of UK medicines output. Whether your facility is a large-scale AstraZeneca or GSK site, a mid-size contract development and manufacturing organisation (CDMO) in the Manchester region, or a growing biotech start-up building its first GMP-compliant production facility in the Cambridge science park ecosystem, the requirement for pharmaceutical-grade oil-free compressed air is universal and absolute.<\/p>\n

Post-Brexit, UK pharmaceutical manufacturers must comply simultaneously with MHRA requirements and, where products are exported to the EU, with EMA and EU GMP standards under the UK-EU Mutual Recognition Agreement for Good Manufacturing Practice. This dual compliance obligation makes it more important than ever that compressed air systems are documented to the highest international standard. Ever Power’s pharmaceutical oil-free compressors are supplied with certification packages that satisfy both MHRA and EU Competent Authority requirements, supporting UK manufacturers who need to maintain access to European markets alongside the growing post-Brexit domestic supply chain. Our local UK support team provides site surveys, compressed air audit reports, and compressed air system design consultancy services to pharmaceutical facilities throughout England, Wales, Scotland, and Northern Ireland.<\/p>\n<\/div>\n

<\/p>\n

\n

\u2605 Customer Success Story: UK Pharmaceutical Manufacturer<\/h2>\n
\n
\n
\n

Case Study<\/p>\n

Meridian Biologics Ltd, Stevenage, Hertfordshire<\/h3>\n

Biopharmaceutical Contract Manufacturer | UK GMP Licensed Site<\/p>\n

\"luftkompressor\"The Challenge:<\/strong> Meridian Biologics was expanding its sterile injectable production capacity with the construction of a new Grade B aseptic filling suite and two 2,000-litre bioreactors for monoclonal antibody production. The existing oil-lubricated compressed air system \u2014 dating from the facility’s original construction in 2007 \u2014 was failing to meet the new suite’s ISO 8573-1 Class 0 requirements during routine monitoring, with oil carry-over events recorded on three occasions in 18 months. The MHRA raised a Major observation during a routine GMP inspection, requiring a Corrective and Preventive Action (CAPA) plan that included a full review of the compressed air supply system. Meridian needed a reliable, validated, pharmaceutical-grade oil-free compressed air solution that could support both existing operations and the new capacity expansion simultaneously.<\/p>\n

The Solution:<\/strong> Ever Power supplied and commissioned two 160 kW twin-stage oil-free screw compressors operating in a duty\/standby configuration, integrated with a dedicated heatless regenerative desiccant dryer train delivering \u221270\u00b0C PDP and a three-stage filtration system providing confirmed Class 0\/1\/1 air quality at the point of use. The installation included full GMP validation documentation \u2014 IQ, OQ, and PQ protocols \u2014 prepared by Ever Power’s pharmaceutical application engineers and reviewed by Meridian’s Qualified Person (QP) prior to execution. A continuous online oil vapour monitor was integrated with the facility’s BMS to provide real-time alerting and data logging for batch record inclusion. The entire installation, qualification, and CAPA closure was completed within 14 weeks of order placement.<\/p>\n

The Results:<\/strong> Following commissioning, Meridian achieved zero oil carry-over events across 18 months of continuous monitoring, successfully closed the MHRA CAPA, and received a complimentary observation from the inspectorate at the subsequent GMP inspection acknowledging the quality of the compressed air system documentation. Annual energy consumption for compressed air generation fell by 28% compared to the previous system, representing a saving of approximately \u00a367,000 per year at current UK electricity tariffs. The new aseptic filling suite was successfully validated and achieved its first commercial batch release within the planned timeline, supporting Meridian’s contract commitments to their pharmaceutical partner clients.<\/p>\n<\/div>\n<\/div>\n

\n
\n

28%<\/p>\n

Energy Saving Achieved<\/p>\n<\/div>\n

\n

\u00a367K<\/p>\n

Annual Cost Reduction<\/p>\n<\/div>\n

\n

14 wks<\/p>\n

Delivery to Qualification<\/p>\n<\/div>\n

\n

0<\/p>\n

Oil Events in 18 Months<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

What UK Pharmaceutical Engineers Say About Ever Power<\/h2>\n
\n
\n

\u2605\u2605\u2605\u2605\u2605<\/p>\n

“We were under significant regulatory pressure to replace our legacy compressed air system following an MHRA inspection observation. Ever Power’s team understood the GMP documentation requirements from day one and delivered a fully validated oil-free compressor installation that met our qualification timeline without any slippage. The technical quality of the IQ\/OQ\/PQ documentation was exceptional \u2014 our QP signed off the validation package first time with no queries. We have since placed a second order for a sister site in Cambridge.”<\/p>\n

David Harrington<\/p>\n

Head of Engineering, Sterling Pharma Solutions \u2014 Cramlington, Northumberland<\/p>\n<\/div>\n

\n

\u2605\u2605\u2605\u2605\u2605<\/p>\n

“As a CDMO specialising in biologics, our compressed air system is as critical as our sterile filtration train. We evaluated four suppliers before selecting Ever Power, and the deciding factors were the depth of their pharmaceutical application knowledge and the quality of their Class 0 certification evidence. Eighteen months into operation, the system has performed flawlessly \u2014 no oil carry-over events, rock-solid pressure delivery, and the energy consumption is well below our initial projections. The VSD control is brilliantly responsive to our highly variable demand profile across different production campaigns.”<\/p>\n

Dr. Sarah Whitfield<\/p>\n

Director of Manufacturing Sciences, Alvotech UK Ltd \u2014 Edinburgh, Scotland<\/p>\n<\/div>\n

\n

\u2605\u2605\u2605\u2605\u2605<\/p>\n

“What I appreciate most about Ever Power is that they don’t just sell compressors \u2014 they sell pharmaceutical-grade compressed air solutions. From the initial site survey and compressed air demand analysis, through system design and equipment selection, to installation supervision and validation support, their team demonstrated genuine expertise in GMP manufacturing environments. The price was competitive and the lead time was exactly as promised. Our new oral solid dosage facility in Swindon has been running on Ever Power oil-free compressors<\/a> since commissioning and we haven’t had a single air quality deviation in 26 months of production.”<\/p>\n

James Fielding<\/p>\n

Site Services Manager, Aesica Pharmaceuticals \u2014 Swindon, Wiltshire<\/p>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Custom Pharmaceutical Compressed Air Systems \u2014 Engineered to Your GMP Specification<\/h2>\n
\n
\n

\ud83c\udfed World-Class Manufacturing Capability<\/h3>\n

Our manufacturing facility operates across 85,000 m\u00b2 of production floor space with an annual output capacity exceeding 6,000 compressor units. The factory holds ISO 9001:2015, ISO 14001:2015, and AS9100D quality certifications, with a dedicated pharmaceutical product line managed under stringent quality assurance protocols. In-house capabilities include precision machining of rotor profiles, dynamic balancing of rotating assemblies, factory pressure testing to 150% of rated pressure, and comprehensive performance testing with calibrated instrumentation traceable to national measurement standards.<\/p>\n<\/div>\n

\n

\u2699\ufe0f Pharmaceutical Customisation Services<\/h3>\n

We understand that no two pharmaceutical manufacturing sites have identical compressed air requirements. Ever Power offers an extensive range of product customisation options specifically developed for the pharmaceutical industry: stainless steel internal pipework and fittings for enhanced corrosion resistance, ATEX Zone 1\/2 classification for facilities handling flammable solvents, clean room-compatible housing with smooth wipe-down exterior surfaces, integrated redundancy (N+1) configurations for critical applications where any downtime is unacceptable, custom pressure vessel inspection schedules aligned with your site’s PED compliance calendar, and bespoke control panel configurations to match existing site DCS standards. Our pharmaceutical application engineers work directly with your project team to define the precise specification before manufacture begins.<\/p>\n<\/div>\n

\n

\ud83d\udce6 Complete System Supply & UK Aftercare<\/h3>\n

Ever Power supplies complete pharmaceutical compressed air systems \u2014 not just individual compressors. A typical pharmaceutical supply package includes the oil-free compressor(s), pre-filtration, heatless or heated desiccant dryer, final sterile filtration, receiving vessel with integrated pressure regulation, continuous oil vapour monitoring, point-of-use filter manifolds, and all interconnecting stainless steel pipework. After handover, our UK service network provides comprehensive aftercare including annual service contracts, 24\/7 emergency call-out, genuine spare parts supply from UK-held stock, and ongoing compressed air quality monitoring and certification services to support your MHRA-required periodic system requalification.<\/p>\n<\/div>\n<\/div>\n

\ud83d\udcec Get a Custom Quote \u2014 Contact Our Pharmaceutical Team Today<\/a><\/div>\n<\/div>\n

<\/p>\n

\n

Vanliga fr\u00e5gor<\/h2>\n

Answers to the questions UK pharmaceutical manufacturers most commonly ask about oil-free compressed air systems.<\/p>\n

\nWhat type of air compressor do I actually need for a GMP-certified pharmaceutical manufacturing facility in the UK, and how do I know it meets MHRA requirements? \uff0b<\/span><\/summary>\n
For any pharmaceutical manufacturing facility operating under a UK Manufacturing Authorisation (MA) regulated by the MHRA, the compressor technology you need is an oil-free air compressor \u2014 specifically one certified to ISO 8573-1:2010 Class 0 for oil content. This means the compressed air delivered by the machine contains zero detectable oil aerosol, oil vapour, or liquid oil. The two most common types for pharmaceutical use are dry-running oil-free twin-screw compressors (for medium to large flow rates) and water-injected oil-free screw compressors (which use water instead of oil as the sealing and cooling medium). MHRA compliance is demonstrated through a formal compressed air system qualification incorporating Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) \u2014 all of which Ever Power supports with complete documentation packages. A Class 0 certification from an independent accredited test body such as T\u00dcV S\u00dcD is the primary documentary evidence required by MHRA inspectors to confirm that the compressed air supply meets GMP requirements at the machine level.<\/div>\n<\/details>\n
\nHow much does a pharmaceutical-grade oil-free air compressor cost for a UK drug manufacturing site, and what factors affect the price I should expect to pay? \uff0b<\/span><\/summary>\n
The price of a pharmaceutical-grade oil-free air compressor varies considerably depending on flow rate (free air delivery), operating pressure, motor power, cooling method, VSD inclusion, and the scope of the ancillary equipment included in the package. As a broad guide for UK buyers, a standalone oil-free compressor unit suitable for a small to mid-size pharmaceutical facility (typically 22\u201355 kW motor, 3\u20138 m\u00b3\/min FAD at 7\u20138 bar) will typically range from \u00a318,000 to \u00a355,000 plus VAT for the compressor alone. A complete pharmaceutical-specification compressed air system including dryer, filtration train, receiver vessel, and monitoring instruments for the same capacity range would typically be priced between \u00a335,000 and \u00a3110,000. Larger systems for high-volume production sites or biologics facilities with multiple bioreactors can cost significantly more. Ever Power offers transparent, itemised quotations with no hidden costs \u2014 contact our team with your site air demand data and we will provide a detailed system quotation within 48 hours.<\/div>\n<\/details>\n
\nWhich ISO 8573-1 purity class is actually required for compressed air used in sterile injectable filling lines and aseptic pharmaceutical manufacturing in Britain? \uff0b<\/span><\/summary>\n
For compressed air used in direct product contact applications in sterile and aseptic pharmaceutical manufacturing \u2014 including sterile injectable filling, freeze-drying loading and unloading, primary container handling, and the actuation of filling valves within Grade A\/B environments \u2014 the required ISO 8573-1:2010 purity classes are Class 1 for solid particles (maximum 0.1 \u00b5m particle size and a maximum concentration of 20,000 particles of 0.1\u20130.5 \u00b5m per m\u00b3), Class 1 for water content (pressure dew point of \u2264 \u221270\u00b0C), and Class 0 for oil content (no detectable oil). This Class 0 oil specification is the most demanding level and cannot be achieved reliably by an oil-lubricated compressor with downstream filtration \u2014 it requires a genuinely oil-free compressor at the generation stage. Non-direct-contact applications such as general instrument air, pneumatic tools in non-sterile areas, and secondary packaging may accept slightly relaxed specifications, but any pharmaceutical site seeking MHRA inspection readiness should apply Class 0 oil specification across the entire site compressed air network as best practice.<\/div>\n<\/details>\n
\nWhere can I find a trusted and experienced supplier of Class 0 oil-free air compressors for pharmaceutical applications in England, Scotland, or Wales? \uff0b<\/span><\/summary>\n
Ever Power supplies pharmaceutical-grade oil-free air compressors to customers across the whole of the United Kingdom \u2014 including major pharmaceutical manufacturing regions such as Stevenage, Cambridge, Macclesfield, Cramlington, Middlesbrough, Livingston, Edinburgh, Swindon, and the wider London and South East biotech corridor. Our UK technical sales and application engineering team can arrange on-site compressed air audits and system assessments at no obligation, providing you with a full compressed air demand analysis and system recommendation before you commit to any purchase. To request a site visit or technical consultation, contact our pharmaceutical specialist team directly at sales@luftkompressor-f\u00f6r-lasersk\u00e4rare.com<\/a>. We maintain UK-held stock of key components and typically achieve delivery timescales of 8\u201314 weeks for standard configured pharmaceutical systems from order placement.<\/div>\n<\/details>\n
\nHow do I get an accurate quote for a bespoke oil-free compressed air system designed specifically for my pharmaceutical facility in the UK? \uff0b<\/span><\/summary>\n
The most effective way to obtain an accurate and competitive quote for a custom pharmaceutical compressed air system is to contact Ever Power’s pharmaceutical team with the following information: your site location in the UK; the total compressed air demand at each required pressure (ideally peak, average, and minimum flow rates in m\u00b3\/min or Nm\u00b3\/h); the required air quality specification (ISO 8573-1 class requirements at the point of use); whether the installation will be in a cleanroom or non-cleanroom area; any site-specific constraints such as ATEX requirements, available electrical supply, space limitations, or noise restrictions; and whether you require the supply of the complete system or only the compressor unit(s). Send this information to sales@luftkompressor-f\u00f6r-lasersk\u00e4rare.com<\/a> and our pharmaceutical application engineers will provide a detailed technical and commercial proposal within 48 working hours. Preliminary budget pricing can usually be provided on the same day for standard system configurations.<\/div>\n<\/details>\n
\nWhat is the difference between a dry-running oil-free screw compressor and a water-injected oil-free screw compressor for pharmaceutical manufacturing applications? \uff0b<\/span><\/summary>\n
Both technologies produce Class 0 oil-free compressed air, but they achieve this through different engineering approaches with different advantages for pharmaceutical applications. A dry-running oil-free screw compressor uses precision-machined rotors with very tight clearances and Teflon-based or specialised coatings to seal the compression space without any liquid medium. The compression is performed in two stages with inter-stage cooling. Discharge temperatures are higher, which provides some bacteriostatic effect on the compressed air. These machines are the industry standard for high-volume pharmaceutical applications and are available in the widest range of capacities. A water-injected oil-free screw compressor injects purified water (never oil) into the compression space for sealing, cooling, and lubrication of the rotor surfaces. This produces cooler discharge temperatures, achieves compression in a single stage (simplifying the machine design), and delivers very low discharge temperatures that are gentle on downstream drying equipment. Water-injected machines are typically preferred for smaller pharmaceutical facilities, laboratory environments, and applications where low capital cost and simplicity of maintenance are priorities. Ever Power offers both technologies and our pharmaceutical application engineers will recommend the most appropriate solution for your specific process requirements, site conditions, and budget.<\/div>\n<\/details>\n
\nCan an oil-free air compressor fully meet both MHRA requirements and EU GMP Annex 1 standards simultaneously for UK pharmaceutical sites that export medicines to Europe? \uff0b<\/span><\/summary>\n
Yes \u2014 an oil-free compressor system correctly specified, installed, and qualified to ISO 8573-1 Class 0 standards will simultaneously satisfy both MHRA compressed air requirements and EU GMP Annex 1 requirements for compressed gases used in pharmaceutical manufacturing. The UK-EU Mutual Recognition Agreement for Good Manufacturing Practice means that a GMP-certified UK pharmaceutical site can export medicines to EU member states without re-inspection by European competent authorities, provided the site’s quality systems \u2014 including its compressed air system \u2014 are maintained to a standard equivalent to EU GMP. Ever Power’s validation documentation packages are specifically designed to satisfy both regulatory frameworks, with document structures, test protocols, and reference standards accepted by both MHRA inspectors and EU Competent Authority inspectors during joint or parallel inspections. If you are a UK CDMO or in-house manufacturer with EU export obligations, our team can advise on the specific documentation requirements for your product categories and target EU markets.<\/div>\n<\/details>\n
\nWhen should a UK pharmaceutical manufacturer consider upgrading from an oil-lubricated compressor with filtration to a fully oil-free compressed air system? \uff0b<\/span><\/summary>\n
There are several clear indicators that a UK pharmaceutical manufacturer should prioritise upgrading to an oil-free compressed air system. The most urgent trigger is an MHRA inspection observation or warning letter citing the compressed air system as a GMP risk \u2014 this requires immediate CAPA action and typically mandates oil-free conversion. Other important upgrade triggers include: any recorded oil carry-over event detected by routine compressed air monitoring (even a single event constitutes a potential GMP deviation requiring full investigation); planned expansion into sterile or aseptic manufacturing where ISO 8573-1 Class 0 is an absolute prerequisite; facility upgrades involving new cleanroom qualification where the compressed air system will be included in the validation scope; replacement of ageing lubricated compressors at end-of-life (avoiding like-for-like replacement is the optimal time to upgrade); and product licence applications for new parenteral or sterile products where the compressed air system will be scrutinised as part of the marketing authorisation data package. If any of these situations applies to your facility, contact Ever Power now \u2014 early engagement allows us to design the optimal solution and plan the installation to minimise disruption to ongoing production.<\/div>\n<\/details>\n<\/div>\n

<\/p>\n

\n

Ready to Specify Your Pharmaceutical Oil-Free Compressed Air System?<\/h2>\n

Talk to an Ever Power pharmaceutical application engineer today. We provide free compressed air audits, system sizing, and itemised GMP-compliant quotations for UK pharmaceutical manufacturers of all sizes.<\/p>\n

\ud83d\udce8 Get a Quote \u2014 sales@air-compressor-for-laser-cutter.com<\/a><\/p>\n

redigerad av gzl<\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

GMP-Compliant \u00a0\u00b7\u00a0 ISO 8573-1 Class 0 \u00a0\u00b7\u00a0 MHRA & UKCA Certified Oil-Free Air Compressors for Pharmaceutical Manufacturing The precision-engineered compressed air solution powering drug production lines, aseptic filling, sterile packaging, and fermentation processes across UK pharmaceutical facilities \u2014 meeting the most stringent GMP and MHRA standards without compromise. \ud83d\ude80 Request a Free Custom Quote \u2192 […]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[18],"tags":[],"class_list":["post-195","post","type-post","status-publish","format-standard","hentry","category-application"],"_links":{"self":[{"href":"https:\/\/air-compressor-for-laser-cutter.com\/sv\/wp-json\/wp\/v2\/posts\/195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/air-compressor-for-laser-cutter.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/air-compressor-for-laser-cutter.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/air-compressor-for-laser-cutter.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/air-compressor-for-laser-cutter.com\/sv\/wp-json\/wp\/v2\/comments?post=195"}],"version-history":[{"count":3,"href":"https:\/\/air-compressor-for-laser-cutter.com\/sv\/wp-json\/wp\/v2\/posts\/195\/revisions"}],"predecessor-version":[{"id":227,"href":"https:\/\/air-compressor-for-laser-cutter.com\/sv\/wp-json\/wp\/v2\/posts\/195\/revisions\/227"}],"wp:attachment":[{"href":"https:\/\/air-compressor-for-laser-cutter.com\/sv\/wp-json\/wp\/v2\/media?parent=195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/air-compressor-for-laser-cutter.com\/sv\/wp-json\/wp\/v2\/categories?post=195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/air-compressor-for-laser-cutter.com\/sv\/wp-json\/wp\/v2\/tags?post=195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}